financetom
Business
financetom
/
Business
/
 Media and consumer products company Xcel Brands Q3 revenue misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
 Media and consumer products company Xcel Brands Q3 revenue misses estimates
Nov 19, 2025 2:55 PM

Overview

* Xcel Brands ( XELB ) Q3 revenue fell 42% yr/yr, missing analyst expectations

* Adjusted loss per share for Q3 beats analyst estimates

Outlook

* Company anticipates new brand launches will drive revenue growth in Q4 2025 and beyond

* Company aims to return to profitability and achieve 100 mln social media followers

Result Drivers

* REVENUE DECLINE - Revenue decreased due to lower net licensing fees and prior inventory sell-offs, impacted by cautious consumer spending

* COST REDUCTION - Direct operating costs decreased 23% due to restructuring and transformation efforts

* IMPAIRMENT CHARGE - $5.5 million non-cash impairment charge recognized for Isaac Mizrahi brand

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $1.12 $1.24

Revenue mln mln (2

Analysts

)

Q3 Beat -$0.34 -$0.71

Adjusted (1

EPS Analyst)

Q3 EPS -$2.02

Q3 Net -$7.99

Income mln

Q3 Gross $1.12

Profit mln

Q3 -$7.44

Operatin mln

g Income

Q3 -$7.96

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the entertainment production peer group is "buy"

* Wall Street's median 12-month price target for Xcel Brands Inc ( XELB ) is $5.00, about 83.2% above its November 18 closing price of $0.84

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MannKind's Supplemental BLA for Diabetes Treatment Afrezza Facing 'Limited Regulatory Risk,' Wedbush Says
MannKind's Supplemental BLA for Diabetes Treatment Afrezza Facing 'Limited Regulatory Risk,' Wedbush Says
Oct 13, 2025
12:29 PM EDT, 10/13/2025 (MT Newswires) -- MannKind's ( MNKD ) supplemental biologics license application for Afrezza to treat children and adolescents with type 1 or type 2 diabetes is facing limited regulatory risk as the company aims for an approval that would expand the drug's addressable market by another 300,000 patients, Wedbush said in a Monday note. Wedbush said...
Market Chatter: Baker Hughes Reports Over $100 Million Tariff Impact as Expected
Market Chatter: Baker Hughes Reports Over $100 Million Tariff Impact as Expected
Oct 13, 2025
12:29 PM EDT, 10/13/2025 (MT Newswires) -- Baker Hughes ( BKR ) has seen a tariff impact of over $100 million this year, in line with its guidance provided in April, Bloomberg reported Monday, citing Chief Executive Officer Lorenzo Simonelli. It is an incremental pressure point, but it's something we have to manage through, Bloomberg quoted Simonelli as saying at...
Broadcom, OpenAI to Deploy 10 GW of Custom AI Accelerators
Broadcom, OpenAI to Deploy 10 GW of Custom AI Accelerators
Oct 13, 2025
12:24 PM EDT, 10/13/2025 (MT Newswires) -- Broadcom ( AVGO ) and Microsoft ( MSFT )-backed (MSFT) OpenAI agreed to deploy 10 gigawatts of custom artificial intelligence accelerators, sending the chipmaker's shares rallying on Monday. OpenAI will design the accelerators and systems that are slated for deployment by the semiconductor company beginning in the second half of 2026. Financial details...
ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan
ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan
Oct 13, 2025
ENDRA Life Sciences Inc. ( NDRA ) shares jumped after the company announced $4.9 million in funding commitments from institutional and cryptocurrency investors to launch a new digital asset treasury strategy. The initiative will focus on high-conviction decentralized finance holdings managed by Arca Investment Management LLC. The private placement includes 744,340 shares of common stock, as well as prefunded warrants...
Copyright 2023-2026 - www.financetom.com All Rights Reserved